DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback
CompuGroup Medical SE: Release of a capital market information

03.09.2018 / 13:41
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement

CompuGroup Medical SE / Share Buyback

Koblenz, September 3, 2018

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 7th Interim Announcement

In the period from August 27, 2018, up to and including August 31, 2018, CompuGroup Medical SE has bought back a total of 35,547 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of July 13, 2018, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on July 16, 2018.

The overall volume of the shares bought back daily in the period from August 27, 2018, up to and including August 31, 2018, and the daily volumeweighted average stock market prices of the shares are as follows:

Date Overall volume of Volume-weighted average stock
shares bought back market price
(number) (EUR, excluding ancillary
costs of purchase, rounded to
four places according to
commercial practice)
August 27, 2018 5,254 50.9603
August 28, 2018 7,300 51.1479
August 29, 2018 9,218 51.4979
August 30, 2018 3,350 50.9918
August 31, 2018 10,425 50.1905
In total: 35,547 50.9154

The total number of shares which have been bought back so far by CompuGroup Medical SE since July 16, 2018, up to and including August 31, 2018, within the framework of the share buyback program thus amounts to 258,624 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

Koblenz, September 3, 2018

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200



03.09.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

720075  03.09.2018 

fncls.ssp?fn=show_t_gif&application_id=720075&application_name=news&site_id=zonebourse